How to Cut Expenses for the Future of Novex

I restructured the management team. We reduced over $650 million of current liability for this organization, helping to strengthen our balance sheet. And right now, according to our base plan, we have the cash runway to get us in a healthy way through the fall and give us a great shot to launch our vaccine. Other changes that we made were changing the way we work with FDA. Changing the how we work internally, being more open and transparent than ever before with FDA on what we can and cannot do.